LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļLIVN
āļāļ·āđāļāļāļĢāļīāļĐāļąāļLivaNova PLC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 19, 2015
āļāļĩāļāļĩāđāļMakatsaria (Vladimir A)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ2900
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļOct 19
āļāļĩāđāļāļĒāļđāđ20 Eastbourne Terrace
āđāļĄāļ·āļāļLONDON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited Kingdom
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđW2 6LG
āđāļāļĢāļĻāļąāļāļāđ442033250662
āđāļ§āđāļāđāļāļāđhttps://www.livanova.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļLIVN
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 19, 2015
āļāļĩāļāļĩāđāļMakatsaria (Vladimir A)
Mr. Alex Shvartsburg
Chief Financial Officer
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
Mr. Todd C. Schermerhorn
Independent Director
Dr. Sharon O'Kane, Ph.D.
Independent Director
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
Ms. Brooke Story
Independent Director
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
Dr. Ahmet Tezel
Chief Innovation Officer
Ms. Susan M. Podlogar
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Alex Shvartsburg
Chief Financial Officer
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
Mr. Todd C. Schermerhorn
Independent Director
Dr. Sharon O'Kane, Ph.D.
Independent Director
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit